421 related articles for article (PubMed ID: 22017929)
1. Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis.
Inoue T; Croce K; Morooka T; Sakuma M; Node K; Simon DI
JACC Cardiovasc Interv; 2011 Oct; 4(10):1057-66. PubMed ID: 22017929
[TBL] [Abstract][Full Text] [Related]
2. Are impaired endothelial progenitor cells involved in the processes of late in-stent thrombosis and re-endothelialization of drug-eluting stents?
Zhao FH; Chen YD; Jin ZN; Lu SZ
Med Hypotheses; 2008; 70(3):512-4. PubMed ID: 17764856
[TBL] [Abstract][Full Text] [Related]
3. [Drug-eluting stent-associated thrombosis: clinical relevance of impaired vessel-wall healing].
Koziński M; Sukiennik A; Sinkiewicz W; Kochman W; Kubica J
Postepy Hig Med Dosw (Online); 2008 May; 62():185-205. PubMed ID: 18464681
[TBL] [Abstract][Full Text] [Related]
4. The Genous™ endothelial progenitor cell capture stent accelerates stent re-endothelialization but does not affect intimal hyperplasia in porcine coronary arteries.
van Beusekom HM; Ertaş G; Sorop O; Serruys PW; van der Giessen WJ
Catheter Cardiovasc Interv; 2012 Feb; 79(2):231-42. PubMed ID: 21834062
[TBL] [Abstract][Full Text] [Related]
5. Effect of a novel peptide, WKYMVm- and sirolimus-coated stent on re-endothelialization and anti-restenosis.
Jang EJ; Bae IH; Park DS; Lee SY; Lim KS; Park JK; Shim JW; Sim DS; Jeong MH
J Mater Sci Mater Med; 2015 Oct; 26(10):251. PubMed ID: 26438653
[TBL] [Abstract][Full Text] [Related]
6. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy.
Curcio A; Torella D; Indolfi C
Circ J; 2011; 75(6):1287-96. PubMed ID: 21532177
[TBL] [Abstract][Full Text] [Related]
8. Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-eluting stent implantation.
Iaccarino D; Politi L; Rossi R; Sgura F; Monopoli D; Modena MG; Sangiorgi GM
J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):536-43. PubMed ID: 20090547
[TBL] [Abstract][Full Text] [Related]
9. Eluting combination drugs from stents.
Thipparaboina R; Khan W; Domb AJ
Int J Pharm; 2013 Sep; 454(1):4-10. PubMed ID: 23850234
[TBL] [Abstract][Full Text] [Related]
10. The importance of the endothelium in atherothrombosis and coronary stenting.
Otsuka F; Finn AV; Yazdani SK; Nakano M; Kolodgie FD; Virmani R
Nat Rev Cardiol; 2012 May; 9(8):439-53. PubMed ID: 22614618
[TBL] [Abstract][Full Text] [Related]
11. Comparative healing response after sirolimus- and paclitaxel-eluting stent implantation in a pig model of restenosis.
Silva GV; Fernandes MR; Madonna R; Clubb F; Oliveira E; Jimenez-Quevedo P; Branco R; Lopez J; Angeli FS; Sanz-Ruiz R; Vaughn WK; Zheng Y; Baimbridge F; Canales J; Cardoso CO; Assad JA; Falotico R; Perin EC
Catheter Cardiovasc Interv; 2009 May; 73(6):801-8. PubMed ID: 19309735
[TBL] [Abstract][Full Text] [Related]
12. Systemic immunosuppressive therapy with oral Sirolimus after bare metal stent implantation: the missing alternative in the prevention of coronary restenosis after percutaneous coronary interventions.
Rodriguez AE; Fernandez-Pereira C
Recent Pat Cardiovasc Drug Discov; 2008 Nov; 3(3):201-8. PubMed ID: 18991795
[TBL] [Abstract][Full Text] [Related]
13. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
[TBL] [Abstract][Full Text] [Related]
14. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A
Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402
[TBL] [Abstract][Full Text] [Related]
15. Sirolimus- and taxol-eluting stents differ towards intimal hyperplasia and re-endothelialization.
Liuzzo JP; Ambrose JA; Coppola JT
J Invasive Cardiol; 2005 Sep; 17(9):497-502. PubMed ID: 16145242
[TBL] [Abstract][Full Text] [Related]
16. Coronary artery stents: Part I. Evolution of percutaneous coronary intervention.
Newsome LT; Kutcher MA; Royster RL
Anesth Analg; 2008 Aug; 107(2):552-69. PubMed ID: 18633035
[TBL] [Abstract][Full Text] [Related]
17. Anti-CD34 antibodies immobilized on the surface of sirolimus-eluting stents enhance stent endothelialization.
Nakazawa G; Granada JF; Alviar CL; Tellez A; Kaluza GL; Guilhermier MY; Parker S; Rowland SM; Kolodgie FD; Leon MB; Virmani R
JACC Cardiovasc Interv; 2010 Jan; 3(1):68-75. PubMed ID: 20129572
[TBL] [Abstract][Full Text] [Related]
18. The union of anti-CD34 antibody can improve the performance of drug-eluting stents.
Yang XS; Zhu HG; Yu ZJ; Ren F; Chen YQ; Wu X; Zhang ZC; Zhang LJ; Lu SZ
Catheter Cardiovasc Interv; 2012 May; 79(6):972-8. PubMed ID: 22162277
[TBL] [Abstract][Full Text] [Related]
19. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]